Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. DORKHAN
Glycaemic and Nonglycaemic Effects of Pioglitazone in Triple Oral Therapy of Patients With Type 2 Diabetes
Journal of Internal Medicine
Internal Medicine
Related publications
Different Glycaemic Patterns in Patients With Steroid Diabetes and Type 2 Diabetes
Endocrine Abstracts
Triple Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy: Changes in Liver Fibrosis Scores After 2 Years of Treatment in Patients With New-Onset Type 2 Diabetes Mellitus
Metabolism: Clinical and Experimental
Endocrinology
Metabolism
Diabetes
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Causes of the Oral Therapy Secondary Failure in Patients With Diabetes Mellitus Type 2
Scripta Medica
Oral Antihyperglycemic Therapy for Type 2 Diabetes
JAMA - Journal of the American Medical Association
Medicine
Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
JAMA - Journal of the American Medical Association
Medicine
Combination Therapy With DPP-4 Inhibitors and Pioglitazone in Type 2 Diabetes: Theoretical Consideration and Therapeutic Potential
Vascular Health and Risk Management
Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-On to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
